LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-9.49 Cr | ₹7.35 Cr | ₹-6.17 Cr | ₹-0.16 Cr | ₹-0.11 Cr |
What is the latest Cash Flow from Investing Activities ratio of LYKA LABS ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-9.49 Cr |
Mar2023 | ₹7.35 Cr |
Mar2022 | ₹-6.17 Cr |
Mar2021 | ₹-0.16 Cr |
Mar2020 | ₹-0.11 Cr |
How is Cash Flow from Investing Activities of LYKA LABS Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-9.49 Cr | Negative | |
Mar2023 | ₹7.35 Cr | Positive | |
Mar2022 | ₹-6.17 Cr | Negative | |
Mar2021 | ₹-0.16 Cr | Negative | |
Mar2020 | ₹-0.11 Cr | - |
Compare Cash Flow from Investing Activities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹414.5 Cr | -1.6% | 8.4% | 15% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 1.4% | 1.3% | 17% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -1.6% |
8.4% |
15% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses